Bioprinting 3D tissues for testing COVID-19 therapeutics: an interview with CLECELL

Written by 3DMedNet

In this editorial/interview, Hyo-Kyung, Bae (CLECELL, Gyeonggi-do, Republic of Korea) describes how the team at CLECELL are utilizing bioprinting techniques to develop tissue models for testing vaccines and therapeutics for COVID-19. As teams of scientists around the world work to develop strategies for the treatments and prevention of COVID-19 through therapeutics and vaccination, there is a unique opportunity for 3D bioprinted tissue models to aid the early R&D phases. In this editorial and interview, Hyo-Kyung, Bae (CLECELL, Gyeonggi-do, Republic of Korea) describes how her team are utilizing bioprinting techniques to develop tissue models and how these can be adapted for...

To view the full article, please register now for access

It's completely free